tiprankstipranks
Trending News
More News >
Medibank Private Ltd. (AU:MPL)
:MPL
Australian Market

Medibank Private (MPL) Financial Statements

Compare
50 Followers

Medibank Private Financial Overview

Medibank Private's market cap is currently AU$13.08B. The company's EPS TTM is AU$0.177; its P/E ratio is 26.72; and it has a dividend yield of 5.70%. Medibank Private is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is AU$0.10. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 8.02BAU$ 7.46BAU$ 7.20BAU$ 6.98BAU$ 6.83B
Gross ProfitAU$ 8.02BAU$ 7.46BAU$ 7.20BAU$ 6.98BAU$ 6.83B
Operating IncomeAU$ 7.00BAU$ 730.30MAU$ 557.90MAU$ 636.10MAU$ 453.60M
EBITDAAU$ 724.20MAU$ 520.60MAU$ 635.10MAU$ 0.00AU$ 0.00
Net IncomeAU$ 492.50MAU$ 511.10MAU$ 393.90MAU$ 441.20MAU$ 315.00M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 927.90MAU$ 420.60MAU$ 596.70MAU$ 671.70MAU$ 871.40M
Total AssetsAU$ 4.69BAU$ 4.39BAU$ 4.55BAU$ 3.92BAU$ 3.75B
Total DebtAU$ 218.30MAU$ 55.30MAU$ 76.90MAU$ 93.40MAU$ 109.20M
Net DebtAU$ -472.70MAU$ -365.30MAU$ -519.80MAU$ -578.30MAU$ -762.20M
Total LiabilitiesAU$ 2.38BAU$ 2.30BAU$ 2.61BAU$ 2.02BAU$ 1.95B
Stockholders' EquityAU$ 2.31BAU$ 2.08BAU$ 1.95BAU$ 1.91BAU$ 1.80B
Cash Flow
Free Cash FlowAU$ 810.90MAU$ 216.30MAU$ 927.60MAU$ 463.10MAU$ 570.90M
Operating Cash FlowAU$ 868.50MAU$ 258.20MAU$ 962.70MAU$ 498.20MAU$ 600.20M
Investing Cash FlowAU$ -110.80MAU$ -15.20MAU$ -637.80MAU$ -322.10MAU$ 81.40M
Financing Cash FlowAU$ -487.30MAU$ -419.10MAU$ -399.90MAU$ -375.80MAU$ -466.70M
Currency in AUD

Medibank Private Earnings and Revenue History

Medibank Private Debt to Assets

Medibank Private Cash Flow

Medibank Private Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis